Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.74 |
| ▸ | APP | P05067 | 3/20 | 0.73 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.68 |
| ▸ | MET | P08581 | 8/20 | 0.66 |
| ▸ | CA12 | O43570 | 5/20 | 0.66 |
| ▸ | CA4 | P22748 | 5/20 | 0.66 |
| ▸ | CA6 | P23280 | 5/20 | 0.66 |
| ▸ | CA5A | P35218 | 5/20 | 0.66 |
| ▸ | CA7 | P43166 | 5/20 | 0.66 |
| ▸ | CA9 | Q16790 | 5/20 | 0.66 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.66 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.64 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14232132 | 1.00 | MAOB (0.74) | MAOBAPPEPHX2METCA12 | |
| SCHEMBL9044207 | 0.90 | APP (0.73) | MAOBAPPEPHX2MAPTMAOA | |
| SCHEMBL9044203 | 0.90 | APP (0.73) | MAOBAPPEPHX2MAPTMAOA | |
| SCHEMBL23310889 | 0.89 | APP (0.77) | MAOBAPPEPHX2METCA12 | |
| SCHEMBL28519058 | 0.88 | FDPS (0.65) | MAOBAPPEPHX2METHSD17B10 | |
| SCHEMBL23869888 | 0.88 | APP (0.60) | MAOBAPPEPHX2METCA12 | |
| SCHEMBL434930 | 0.88 | MAOB (0.76) | MAOBAPPEPHX2METCA12 | |
| SCHEMBL10054940 | 0.88 | MAOB (0.76) | MAOBAPPEPHX2METCA12 | |
| SCHEMBL27520787 | 0.88 | MAOB (0.76) | MAOBAPPEPHX2METCA12 | |
| Curcumin SCHEMBL1665539 | 0.86 | APP (0.76) | MAOBAPPCA12CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112043716-A | Pharmaceutical composition with neuroprotective activity, extraction method and application thereof | 深圳红景堂生物医药科技有限公司 | 2020-12-08 | — | — | CN | claimed |
| CN-116179509-A | Method for synthesizing phenyl acrylate by feruloyl esterase catalysis | 广西大学 | 2023-05-30 | — | — | CN | disclosed |
| CN-106692961-B | Arginase composition, arginase activator and application thereof | 长春市福迪奥美科技有限公司 | 2020-12-11 | — | — | CN | disclosed |
| CN-112043716-A | Pharmaceutical composition with neuroprotective activity, extraction method and application thereof | 深圳红景堂生物医药科技有限公司 | 2020-12-08 | — | — | CN | disclosed |
| CN-112043716-A | Pharmaceutical composition with neuroprotective activity, extraction method and application thereof | 深圳红景堂生物医药科技有限公司 | 2020-12-08 | — | — | CN | disclosed |
| CN-110833541-A | Preparation method of ferulic acid butyl ester and functional application of ferulic acid butyl ester in treating or preventing Alzheimer's disease | 浙江工商大学 | 2020-02-25 | — | — | CN | disclosed |
| US-9939555-B2 | Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising cured product thereof | DIC CORPORATION (JP) | 2018-04-10 | — | — | US | disclosed |
| CN-107050100-A | Red stilbene Chinese medicine is taken after being infused in hot water or decoction medicine materical crude slice | 江苏苏轩堂药业有限公司 | 2017-08-18 | — | — | CN | disclosed |
| US-9684206-B2 | Copolymer, and liquid crystal alignment layer including cured product thereof | DIC CORPORATION (JP) | 2017-06-20 | — | — | US | disclosed |
| EP-2727947-B1 | COPOLYMER, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING HARDENED PRODUCT THEREOF | DAINIPPON INK & CHEMICALS (JP) | 2017-03-15 | — | — | EP | disclosed |
| US-20140121345-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| CN-103619803-A | Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising cured product thereof | DAINIPPON INK & CHEMICALS | 2014-03-05 | — | — | CN | disclosed |
| US-20110002968-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING AN ORCHID EXTRACT, AND COSMETIC CARE METHOD USING SAID COMPOSITION | LVMH RECHERCHE (FR) | 2011-01-06 | — | — | US | disclosed |
| US-20100291151-A1 | 1-METHYLPYRAZOLE MODULATORS OF SUBSTANCE P, CALCITONIN GENE-RELATED PEPTIDE, ADRENERGIC RECEPTOR, AND/OR 5-HT RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-11-18 | — | — | US | disclosed |
| JP-2005015453-A | COSMETIC COMPOSITION CONTAINING ISOSTEARYL FERULATE | MATSUMOTO TRADING CO LTD | 2005-01-20 | — | — | JP | disclosed |
| US-6436991-B1 | FERULATE COMPOUNDS | SABINSA CORPORATION | 2002-08-20 | — | — | US | disclosed |
| US-20020061929-A1 | Ferulate compounds | SAMI LABS LIMITED (IN) | 2002-05-23 | — | — | US | disclosed |
| JP-2002030039-A | METHOD FOR PRODUCING CARCINOGENESIS PREVENTING SUBSTANCE | WAKAYAMA PREFECTURE | 2002-01-29 | — | — | JP | disclosed |
| WO-2001090064-A2 | COMPOSITION AND METHOD CONTAINING PRODUCTS EXTRACTED FROM COMMIPHORA Sp. FOR PREVENTION AND TREATMENT OF ABNORMAL CELL GROWTH AND PROLIFERATION IN INFLAMMATION, NEOPLASIA AND CARDIOVASCULAR DISEASE | SABINSA CORPORATION (US) | 2001-11-29 | — | — | WO | disclosed |
| EP-0742012-A2 | Pharmaceutical composition containing substance inhibiting HSP47 production | Kureha Chemical Industry Co., Ltd. (JP) | 1996-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100291151-A1 | 1-METHYLPYRAZOLE MODULATORS OF SUBSTANCE P, CALCITONIN GENE-RELATED PEPTIDE, ADRENERGIC RECEPTOR, AND/OR 5-HT RECEPTOR | TACR1, HTR3A, HTR3C | MAOB 287/4885APP 599/4885EPHX2 1615/4885 |
| US-20020061929-A1 | Ferulate compounds | FER, FIBP, VHL | MAOB 1178/4885APP 4566/4885EPHX2 3633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.